PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus. - Wikidata - wikimedia - TriplyDB

PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.

PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q33811239

about

Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis Relationship between a novel polymorphism of the C5L2 gene and coronary artery disease.The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease.KCNQ1 gene polymorphisms are associated with lipid parameters in a Chinese Han population.Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study.Association of the variants in the PPARG gene and serum lipid levels: a meta-analysis of 74 studies.Gene-Gene Interactions among Pparα/δ/γ Polymorphisms for Apolipoprotein (Apo) A-I/Apob Ratio in Chinese Han Population PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome Distribution and genotype frequency of the C1431T and pro12ala polymorphisms of the peroxisome proliferator activator receptor gamma gene in an Iranian population.The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.PPARG gene C161T CT/TT associated with lower blood lipid levels and ischemic stroke from large-artery atherosclerosis in a Han population in Guangdong.Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease.The C161T polymorphism in the peroxisome proliferator-activated receptor gamma gene (PPARγ) is associated with risk of coronary artery disease: a meta-analysis.Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus.The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles.Role of PPARG (Pro12Ala) in Malaysian type 2 diabetes mellitus patients PPAR𝛾 gene and atherosclerosis: Genetic polymorphisms, epigenetics and therapeutic implications

P2860

Q26766459-4327FBCE-4334-43CB-BF3B-27F6A9BC9250 Q30248537-DCEE55C1-D0C9-4ADF-B3BE-D6D544B62FD9 Q33940989-526284AA-8993-482D-A546-FED3E0140D62 Q34019843-35738D31-6F1F-4CC5-9EB3-4950DBD2E235 Q34078271-910E1E0D-B9BC-42FB-9B7F-1283571F3139 Q34419027-3AE1AD99-F9B6-4750-B428-F93060BE1F79 Q34885498-43487818-B8C4-49A4-96DC-B74FF50915C0 Q35763261-DB16B42F-7792-4728-8BE4-FB0934A508F6 Q35808814-5122AB80-E73E-4740-AC98-607D05D11F93 Q37498438-184C7C07-E8DC-4488-B4D1-EBF34F489F8C Q38044273-21E3EE2F-5B3C-4791-9780-F7606F244527 Q40717921-9A76BE59-CF45-4CD0-8EE4-3C62F50180CE Q48189776-D40E8985-B62F-4F60-BD99-7875C3829D2C Q53111637-42AD1D30-5AEF-4832-BEA2-2B4C9388637E Q53843076-A6CAFA6B-0ED8-4572-92A1-C15C0088F294 Q55382917-F02590F4-0FC1-4ADE-BCF4-DA3EAF288BEC Q57278795-0685FB86-ED43-4D75-BD8F-E42295CBD060 Q58690872-D91B52C3-8C13-4AA6-98B1-923912D45A3D

P2860

PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q33811239

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

PPARgamma gene C161T substitut ...... and type 2 diabetes mellitus.

@ast

PPARgamma gene C161T substitut ...... and type 2 diabetes mellitus.

@en

type

label

PPARgamma gene C161T substitut ...... and type 2 diabetes mellitus.

@ast

PPARgamma gene C161T substitut ...... and type 2 diabetes mellitus.

@en

prefLabel

PPARgamma gene C161T substitut ...... and type 2 diabetes mellitus.

@ast

PPARgamma gene C161T substitut ...... and type 2 diabetes mellitus.

@en

P1433

Q33811239-65469394-B75F-45C7-B966-93BA41060187

P1476

Q33811239-0D438584-4091-4253-93B2-8A5CAAFA3B88

P2093

Q33811239-34B03AE0-2D9E-4BD2-ADEA-53B040542F5F

Q33811239-47B4A129-5AA5-49F4-8A8E-AAC3D656D714

Q33811239-6056F90B-1CAA-4940-B72E-1E5804A31520

Q33811239-7B8E1A6D-81E4-4936-A043-48B32437DBEA

Q33811239-7CE51541-E8F5-43A4-A427-EAF6738B82FB

Q33811239-A7E8B18B-148C-4F60-B4A8-0E9C71EEC745

Q33811239-C9C1C5D3-9934-454A-A691-1141D62AC858

P2860

Q33811239-06C15E33-D03D-4913-9EB4-D365F90091DD

Q33811239-1EA9E54E-1AD8-4F5D-879A-0052FC363CB7

Q33811239-2AF5FA1A-57FD-41F4-919D-2105A442283F

Q33811239-2E695DEE-4C32-4F55-A045-A9B5F6BEF431

Q33811239-3F8BB09A-F6C3-4CFE-9542-B94095137B38

Q33811239-45671166-B8B7-4C71-9B6F-3BDE43103AB0

Q33811239-4F5E404C-132A-462A-80DD-4FF1CD1DDD94

Q33811239-4FC9F703-82BE-4DE7-801B-0FB6EA3A4C17

Q33811239-69ACA765-CBAE-47B1-965E-894D2A18E75B

Q33811239-77D148DC-C3D6-45E9-9D04-ECB6658E35AA

P2888

Q33811239-F941F8FC-2DAE-4DD5-9BC3-D35996D2353E

P304

Q33811239-29C33ACA-0372-4EE8-A857-E6A9C4290E05

P31

Q33811239-0F2A9912-BEE0-431F-BB1B-DE3200BF11BA

P356

Q33811239-63A08D9A-9859-402A-B216-781133CD6F0C

P407

Q33811239-1976DC79-0475-4ACB-9722-676703EA2500

P478

Q33811239-F0425BBA-817E-4057-8760-72D0E94602E4

P577

Q33811239-E6C7AE9E-5FEB-4AF4-B2C2-B1EAC6FBD5A7

P5875

Q33811239-82A85BD5-08A3-4119-BFCF-D47BA1176093

P6179

Q33811239-442FFAF3-78CD-489F-8EFC-2A99565EC740

P698

Q33811239-B651F7B1-5A0C-400D-A8C9-9ED093496C34

P921

Q33811239-12AC5660-7010-4502-86BF-D0333FAFE736

P932

Q33811239-3CF80E6A-587C-41ED-A1DE-E7B04EE2C8F5

P356

P1433

Cardiovascular Diabetology

P1476

PPARgamma gene C161T substitut ...... and type 2 diabetes mellitus.

@en

P2093

Jianming Xiao

http://www.w3.org/2001/XMLSchema#string

Jing Wan

http://www.w3.org/2001/XMLSchema#string

Jinghua Wang

http://www.w3.org/2001/XMLSchema#string

Sabita Roy

http://www.w3.org/2001/XMLSchema#string

Shengping Chao

http://www.w3.org/2001/XMLSchema#string

Shixi Xiong

http://www.w3.org/2001/XMLSchema#string

Yexin Ma

http://www.w3.org/2001/XMLSchema#string

P2860

PPAR(alpha) and PPAR(gamma) activators suppress the monocyte-macrophage apoB-48 receptor

Atherosclerosis — An Inflammatory Disease

The platelet in diabetes: focus on prevention of ischemic events

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

The role of plaque rupture and thrombosis in coronary artery disease.

Epidemiology of diabetes.

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro.

Role of PPAR- gamma agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: a cardiovascular perspective.

Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator-activated receptor gamma.

Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome.

P2888

P304

13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-9-13

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42540872

http://www.w3.org/2001/XMLSchema#string

P6179

1026412701

http://www.w3.org/2001/XMLSchema#string

P698

20334678

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2859850

http://www.w3.org/2001/XMLSchema#string